Search results
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 5 hours agoThursday, Moderna Inc MRNA reported a first-quarter EPS loss of $(3.07), down from an income of...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 10 hours agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 3 hours agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company’s first quarter ...
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall By Investing.com
Investing.com· 14 hours agoModerna Inc. (NASDAQ:MRNA) reported first-quarter earnings and revenue that came ahead of analyst...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 7 hours agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 14 hours agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Moderna Focused on Cutting Costs, RSV Vaccine
Bloomberg· 10 hours agoModerna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker expects to...
Moderna makes several cost-cutting moves, leans into AI - Boston Business Journal
The Business Journals· 11 hours agoAs Moderna Inc. works toward expanding its approved products beyond its Covid-19 vaccine, the...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
NBC Philadelphia· 14 hours agoModerna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting...
Moderna Beats Quarterly Estimates as Cost-Cutting Pares Losses
Bloomberg· 14 hours agoModerna Inc. reported a narrower first-quarter loss than Wall Street had expected, as the biotech...